JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Travis, D. M.
Right arrow Articles by Maren, T. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Travis, D. M.
Right arrow Articles by Maren, T. H.
Journal of Pharmacology And Experimental Therapeutics, Vol. 143, Issue 3, 383-394, 1964
Copyright © 1964 by American Society for Pharmacology and Experimental Therapeutics

SELECTIVE RENAL CARBONIC ANHYDRASE INHIBITION WITHOUT RESPIRATORY EFFECT: PHARMACOLOGY OF 2-BENZENESULFONAMIDO-1,3,4-THIADIAZOLE-5-SULFONAMIDE (CL 11,366)

David M. Travis 1, Christine Wiley 1, Bohdan R. Nechay 1, and Thomas H. Maren 1

1 Department of Pharmacology and Therapeutics, University of Florida College of Medicine, Gainesville, Florida

Carbonic anhydrase inhibitors including acetazolamide usually elicit physiological responses at various sites in the body without discrimination by dose. These responses, particularly those related to erythrocytic enzyme inhibition, tend to complicate study of any single system. A compound related to acetazolamide, 2-benzene-sulfonamido-1,3,4-thiadiazole-5-sulfonamide (CL 11,366), was found to have properties which make possible a separation of renal from erythrocytic and other effects. Acetazolamide and CL 11,366 were given intravenously to dogs over a wide range of dose. Studies were made of inhibitor distribution and physiological responses in kidney, red blood cells and certain other tisssues.

Acetazolamide at the lowest dose which gives maximal renal HCO3- output (10 mg/kg) gave acute respiratory changes including hyperventilation and a fall in alveolar CO2 tension. This is a dose known to be associated with other responses such as an acute rise in cerebrospinal fluid pressure, decreases in cerebrospinal fluid flow and intraocular pressure, and inhibition of postfeeding gastric acid secretion. By contrast, CL 11,366 was not accompanied by respiratory or the other responses over a range of dose which gave a full renal response (0.3 to 3 mg/kg). Effective erythrocytic enzyme inhibition with respiratory changes occurred at 10 mg/kg.

Elimination of acute respiratory effects during maximal renal carbonic anhydrase inhibition by CL 11,366 is related to 1) partial exclusion of inhibitor from red cells by high plasma binding, ionization and rapid plasma decay, and 2) concentration of inhibitor in kidney by active secretion. Acute respiratory changes were demonstrated to be related to inhibition of erythrocytic carbonic anhydrase (greater than 0.995) independent of the renal HCO3- loss.

The results indicate that selective renal carbonic anhydrase inhibition without acute effects on respiration can be obtained by the use of appropriate doses of CL 11,366.

Submitted on June 18, 1963
Accepted on November 6, 1963




This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. Hohne, P. A. Pickerodt, R. C. Francis, W. Boemke, and E. R. Swenson
Pulmonary vasodilation by acetazolamide during hypoxia is unrelated to carbonic anhydrase inhibition
Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L178 - L184.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Biol.Home page
S. F. Perry1, K. M. Gilmour, E. R. Swenson, B. Vulesevic, S. F. Chew, and Y. K. Ip
An investigation of the role of carbonic anhydrase in aquatic and aerial gas transfer in the African lungfish Protopterus dolloi
J. Exp. Biol., October 1, 2005; 208(19): 3805 - 3815.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Abdulnour-Nakhoul, N. L. Nakhoul, S. A. Wheeler, P. Wang, E. R. Swenson, and R. C. Orlando
HCO3- secretion in the esophageal submucosal glands
Am J Physiol Gastrointest Liver Physiol, April 1, 2005; 288(4): G736 - G744.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
M. CHESLER
Regulation and Modulation of pH in the Brain
Physiol Rev, October 1, 2003; 83(4): 1183 - 1221.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
E. R. Swenson, T. W. Tewson, P. J. Wistrand, Y. Ridderstrale, and C. Tu
Biochemical, histological, and inhibitor studies of membrane carbonic anhydrase in frog gastric acid secretion
Am J Physiol Gastrointest Liver Physiol, July 1, 2001; 281(1): G61 - G68.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
C.-K. Tong, L. P. Brion, C. Suarez, and M. Chesler
Interstitial Carbonic Anhydrase (CA) Activity in Brain Is Attributable to Membrane-Bound CA Type IV
J. Neurosci., November 15, 2000; 20(22): 8247 - 8253.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
C. K. Tong and M. Chesler
Modulation of Spreading Depression by Changes in Extracellular pH
J Neurophysiol, November 1, 2000; 84(5): 2449 - 2457.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. J. TEPPEMA and A. DAHAN
Acetazolamide and Breathing . Does a Clinical Dose Alter Peripheral and Central CO2 Sensitivity?
Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1592 - 1597.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1964 by the American Society for Pharmacology and Experimental Therapeutics.